Alprazolam
FDA Label NDC 50090-5109

44 label sections · Submitted to the FDA by A-s Medication Solutions · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by A-s Medication Solutions for the product Alprazolam (NDC 50090-5109). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: risks from concomitant use with opioids; abuse, misuse, and addiction; anddependence and withdrawal reactions, 1 indications and usage, 2.1 dosage in generalized anxiety disorder, 2.2 dosage in panic disorder, 2.3 discontinuation or dosage reduction of alprazolam tablets, 2.4 dosage recommendations in geriatric patients, 2.5 dosage recommendations in patients with hepatic impairment, 2.6 dosage modifications for drug interactions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.